爱民制药 (871897.OC)

+ 收藏

利润表(爱民制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表
一、营业总收入(元) 85,166,003.4143,892,741.4453,224,692.2820,898,835.82
 营业收入(元) 85,166,003.4143,892,741.4453,224,692.2820,898,835.82
二、营业总成本(元) 139,792,311.8560,866,841.98116,403,579.0345,235,888.91
 营业成本(元) 36,301,056.0118,088,798.6618,491,180.0810,265,531.11
 研发费用(元) 20,636,997.026,297,332.1216,879,462.755,205,856.46
 营业税金及附加(元) 3,263,385.281,607,186.562,130,994.591,008,943.19
 销售费用(元) 37,923,552.6214,039,729.5935,193,826.4312,120,754.17
 管理费用(元) 33,869,154.4917,268,621.5333,980,435.5313,226,883.82
 财务费用(元) 7,798,166.433,565,173.529,727,679.653,407,920.16
  其中:利息费用(元) 7,691,797.183,470,324.229,742,685.163,495,502.93
  其中:利息收入(元) 16,190.5415,150.42146,334.22104,298.19
三、其他经营收益
 加:投资收益(元) 41,072,152.2227,012,345.20-13,473.83-9,500.00
 资产处置收益(元) 43,577,125.17---
 资产减值损失(元) -237,496.06-316,477.87-651,234.55-158,997.19
 信用减值损失(元) -129,329.13-678,465.023,318,028.582,147,315.58
 其他收益(元) 16,369,855.531,977,408.723,732,271.391,221,303.00
四、营业利润(元) 46,025,999.2911,020,710.49-56,793,295.16-21,136,931.70
 加:营业外收入(元) 1,083,405.6037,884.75272,045.5711,948.64
 减:营业外支出(元) 580,774.52233,157.60449,338.7418,474.26
五、利润总额(元) 46,528,630.3710,825,437.64-56,970,588.33-21,143,457.32
 减:所得税费用(元) -34,682.66-157,106.07467,975.58290,645.35
六、净利润(元) 46,563,313.0310,982,543.71-57,438,563.91-21,434,102.67
(一)按经营持续性分类
  持续经营净利润(元) 46,563,313.0310,982,543.71-57,438,563.91-21,434,102.67
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 47,515,291.6411,514,154.08-57,485,233.75-20,441,812.12
  少数股东损益(元) -951,978.61-531,610.3746,669.84-992,290.55
 扣除非经常性损益后的净利润(元) -53,399,573.3510,064,561.85-60,302,270.49-21,264,020.47
七、每股收益
 一、基本每股收益(元) 0.470.12-0.57-0.20
 二、稀释每股收益(元) 0.47---0.20
九、综合收益总额(元) 46,563,313.0310,982,543.71-57,438,563.91-21,434,102.67
 归属于母公司所有者的综合收益总额(元) 47,515,291.6411,514,154.08-57,485,233.75-20,441,812.12
 归属于少数股东的综合收益总额(元) -951,978.61-531,610.3746,669.84-992,290.55
公告日期 2024-04-292023-08-082023-04-272022-08-23
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院